Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | ethylene dichloride results in increased expression of C21ORF58 mRNA alternative form | CTD | PMID:37028497 | 17beta-estradiol | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of C21ORF58 mRNA | CTD | PMID:31614463 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C20H21ORF58 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of C20H21ORF58 mRNA | CTD | PMID:25825206 | acrylamide | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of C21ORF58 mRNA | CTD | PMID:32763439 | all-trans-retinoic acid | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of C21ORF58 mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of C21ORF58 mRNA | CTD | PMID:24449571 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of C20H21ORF58 mRNA and bisphenol A results in decreased expression of C21ORF58 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C20H21ORF58 mRNA | CTD | PMID:36041667 | bisphenol A | decreases methylation | ISO | C21orf58 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of C21ORF58 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of C21ORF58 mRNA | CTD | PMID:27685785 and PMID:36232920 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C20H21ORF58 mRNA | CTD | PMID:36041667 | butan-1-ol | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of C21ORF58 mRNA | CTD | PMID:29432896 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of C20H21ORF58 promoter | CTD | PMID:22457795 | calcitriol | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of C21ORF58 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of C21ORF58 mRNA | CTD | PMID:21592394 | cannabidiol | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of C21ORF58 mRNA | CTD | PMID:33244087 | clothianidin | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of C21ORF58 mRNA | CTD | PMID:31626844 | copper atom | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of C21ORF58 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of C21ORF58 mRNA | CTD | PMID:20971185 | crocidolite asbestos | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of C21ORF58 mRNA | CTD | PMID:29523930 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of C20H21ORF58 mRNA | CTD | PMID:26577399 | dicrotophos | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of C21ORF58 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C21ORF58 mRNA | CTD | PMID:27188386 | entinostat | affects expression | ISO | C21orf58 (Homo sapiens) | 6480464 | entinostat affects the expression of C21ORF58 mRNA | CTD | PMID:26272509 | ethyl methanesulfonate | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of C21ORF58 mRNA | CTD | PMID:23649840 | gallic acid | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of C21ORF58 mRNA | CTD | PMID:34408198 | leflunomide | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of C21ORF58 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of C21ORF58 mRNA | CTD | PMID:23649840 | N-Nitrosopyrrolidine | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of C21ORF58 mRNA | CTD | PMID:32234424 | paracetamol | increases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of C21ORF58 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of C21ORF58 mRNA | CTD | PMID:29067470 | SB 431542 | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | affects expression | ISO | C21orf58 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of C21ORF58 mRNA | CTD | PMID:34032870 | sunitinib | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of C21ORF58 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of C21ORF58 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of C21ORF58 mRNA | CTD | PMID:21592394 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of C20H21ORF58 mRNA | CTD | PMID:33387578 | urethane | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Urethane results in decreased expression of C21ORF58 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | C21orf58 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of C21ORF58 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | C21orf58 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of C21ORF58 mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | ISO | C21orf58 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C21ORF58 mRNA | CTD | PMID:27188386 | |